Loading...
Loading...
AVANIR Pharmaceuticals, Inc.
AVNR today announced that it has completed the previously announced underwritten public offering of 20,000,000 shares of its common stock, offered at a price of $4.40 per share.
The net proceeds to AVANIR from the sales of shares in this offering, after deducting customary underwriting discounts and commissions, were approximately $83.2 million.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
We simplify the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in